Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
BACKGROUND: Mice lacking the type I interferon receptor (IFNAR-/- mice) reproduce relevant aspects of Crimean-Congo hemorrhagic fever (CCHF) in humans, including liver damage. We aimed at characterizing the liver pathology in CCHF virus-infected IFNAR-/- mice by immunohistochemistry and employed the...
Main Authors: | Lisa Oestereich, Toni Rieger, Melanie Neumann, Christian Bernreuther, Maria Lehmann, Susanne Krasemann, Stephanie Wurr, Petra Emmerich, Xavier de Lamballerie, Stephan Ölschläger, Stephan Günther |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-05-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4006714?pdf=render |
Similar Items
-
Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever
by: Onder Ergonul
Published: (2014-12-01) -
Treatment of Crimean-Congo Haemorrhagic Fever by Favipiravir in a Patient with Novel Coronavirus Co-Infection
by: Ahmet Cumhur Dülger, et al.
Published: (2020-12-01) -
Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis
by: G Gail, et al.
Published: (2010-07-01) -
Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever
by: Hassan Salehi, et al.
Published: (2013-01-01) -
Comparison of Chikungunya Virus Strains in Disease Severity and Susceptibility to T-705 (Favipiravir), In vitro and In vivo
by: Gebre, Makda
Published: (2017)